Sartans, angiotensin II receptor antagonists, can induce psoriasis [8]

British Journal of Dermatology

Volumn 147, Issue 3, 2002, Pages 617-618

  Marquart Elbaz, C ^a   Grosshans, E ^a   Alt, M ^a   Lipsker, D ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CANDESARTAN; CILENGITIDE; IRBESARTAN; LOSARTAN; RETINOID; SARTAN; UNCLASSIFIED DRUG; VALSARTAN;

ADULT; AGED; CELL PROLIFERATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DRUG INDUCED DISEASE; DRUG SELECTIVITY; FEMALE; FOLLOW UP; FRANCE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSORIASIS; RECURRENT DISEASE; SKIN DEFECT; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; LOSARTAN; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0036042577     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.48848.x     Document Type: Letter

References (2)

1. Angiotensin II type 1 receptor blockers
2. Angiotensin II stimulates proliferation of primary human keratinocytes via a non-AT1, non-AT2 angiotensin receptor